# A Trial to Learn How Much Rivaroxaban Gets Into the Blood When Taken in Different Forms and How Safe They Are in Healthy Men

> **NCT04727021** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 30 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** 20 mg tablet rivaroxaban
- **DRUG:** 20 mg rivaroxaban, granules for oral suspension

## Key facts

- **NCT ID:** NCT04727021
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-04
- **Primary completion:** 2017-09-04
- **Final completion:** 2017-10-27
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04727021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04727021, "A Trial to Learn How Much Rivaroxaban Gets Into the Blood When Taken in Different Forms and How Safe They Are in Healthy Men". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04727021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*